Fierce Pharma Fierce Pharma
Webinar

Using longitudinal RWD to boost activation along the patient journey

Available on-demand
60 Minutes

People now play a more active role in their own health—but too often don’t know about relevant care and resources. Relying on traditional data and segmentation means healthcare companies lack critical insights to engage the right patients at the right time in clinically meaningful ways. Using real-world data, you can reach, understand, and activate patients in a way that improves both care and resource optimization.

Learn how companies harness longitudinal real-world data to:

  • Fill in gaps about people’s everyday health missed by traditional data and episodic claims and EHR
  • Build comprehensive patient journeys and more nuanced segments
  • Engage and activate the right individuals to help them and their healthcare providers better detect symptoms, prompt earlier diagnoses, inform treatment decisions, and improve adherence

Speakers

EvidationHealth-HS-Ernesto-3222023.png

Ernesto Ramirez, PhD

Ernesto leads the Consumer Research team at Evidation. He focuses on designing, delivering, and scaling innovative research opportunities and health engagement programs for Evidation members. His research initiatives at Evidation include its recent BARDA-supported studies exploring the role of wearable sensor data in better understanding, classifying, and predicting infectious diseases.

EvidationHealth-HS-Arash-3222023.png

Arash Harzand, MD, MBA

Arash is a cardiologist and clinical investigator, serving as Co-Director and Chief Health Advisor for Digital Health at the VA Office of Healthcare Innovation Learning, Director of Vascular Medicine at the Atlanta VA Health Care System, and Assistant Professor of Medicine at the Emory School of Medicine. He researches the utilization of mobile health to deliver decentralized behavioral interventions to patients.

EvidationHealth-HS-Kalahn-3222023.png

Kalahn Taylor-Clark, PhD, MPH

Kalahn oversees patient-centered advocacy and digital innovation at Myovant Sciences. She is responsible for driving transformative advocacy in the areas of women’s health and prostate cancer, addressing health equity, and advancing digital innovation strategies to improve patient experiences and outcomes. Kalahn has also held positions with Sanofi, George Mason University, the National Partnership for Women and Families, and the Brookings Institution.

Register here to watch on-demand!

Duration:
60 Minutes